The effect of comorbidities on the choice of tyrosine kinase inhibitors in patients with chronic myeloid leukemia
Tyrosine kinase inhibitors (TKIs) approved for chronic myeloid leukemia known to have
similar efficacies but different safety profiles. Therefore, the choice of patient-specific …
similar efficacies but different safety profiles. Therefore, the choice of patient-specific …
[HTML][HTML] Prognosis in chronic myeloid leukemia: baseline factors, dynamic risk assessment and novel insights
M Iezza, S Cortesi, E Ottaviani, M Mancini, C Venturi… - Cells, 2023 - mdpi.com
The introduction of tyrosine kinase inhibitors (TKIs) has changed the treatment paradigm of
chronic myeloid leukemia (CML), leading to a dramatic improvement of the outcome of CML …
chronic myeloid leukemia (CML), leading to a dramatic improvement of the outcome of CML …
Patient characteristics and management practices in chronic myeloid leukemia in Turkey: reflections from an expert meeting
AE Eşkazan, R Ali, E Alnıgeniş, O Ayyıldız… - Expert Review of …, 2022 - Taylor & Francis
Introduction The therapeutic landscape of chronic myeloid leukemia (CML) has evolved
significantly since the introduction of imatinib. The European LeukemiaNet (ELN) …
significantly since the introduction of imatinib. The European LeukemiaNet (ELN) …
Measuring prognosis in chronic myeloid leukemia: what's new?
M Breccia, F Efficace, E Scalzulli, G Ciotti… - Expert Review of …, 2021 - Taylor & Francis
Introduction: The outcome of chronic myeloid leukemia (CML) patients in chronic phase has
changed after the introduction of tyrosine kinase inhibitors (TKIs). The life expectancy is …
changed after the introduction of tyrosine kinase inhibitors (TKIs). The life expectancy is …
НАРУШЕНИЕ ФУНКЦИИ ЖЕЛУДОЧНО-КИШЕЧНОГО ТРАКТА, СВЯЗАННОЙ С ПРИЕМОМ ИМАТИНИБА У БОЛЬНЫХ С ХРОНИЧЕСКИМ МИЕЛОЛЕЙКОЗОМ
АМ Курязов, ХМ Казакбаева… - … и естественных наук, 2023 - journals.tnmu.uz
Аннотация Цель работы. Изучение результатов терапии и нарушений ЖКТ, связанный
с приемом ингибитора тирозинкиназы I поколения–иматиниба в группе больных …
с приемом ингибитора тирозинкиназы I поколения–иматиниба в группе больных …
[引用][C] A clinical appraisal of chronic myeloid leukaemia (CML)-related death and CML-specific death-Are they synonymous?
AE Eşkazan - International Journal of Clinical Practice, 2021 - europepmc.org
A clinical appraisal of chronic myeloid leukaemia (CML)-related death and CML-specific
death-Are they synonymous? - Abstract - Europe PMC Sign in | Create an account https://orcid.org …
death-Are they synonymous? - Abstract - Europe PMC Sign in | Create an account https://orcid.org …